Key result
Leadless pacemaker successfully bridges a patient with fulminant myocarditis and high bleeding risk to CRT.
Why the study?
Direct CRT implantation can be challenging during intensive mechanical circulatory support and systemic steroid therapy due to high risks of bleeding and infection.
Case Report (n=1)
A leadless pacemaker can serve as a safe and effective temporary bridge to cardiac resynchronisation therapy in patients with fulminant myocarditis on mechanical circulatory support who are at high risk for bleeding and infection.
Answers are grounded in this paper and cite their sources.
May support leadless pacing as temporary bridge in high-bleeding-risk myocarditis on MCS; hypothesis-generating, needs prospective validation.
Background: Fulminant myocarditis can result in persistent severe left ventricular dysfunction and complete atrioventricular block (AVB), necessitating cardiac resynchronisation therapy (CRT). However, direct CRT implantation can be sometimes challenging in the context of intensive mechanical circulatory support and systemic steroid therapy, where the risks of procedure-related bleeding and infection are significantly heightened. Case summary: This report describes a 64-year-old woman with fulminant myocarditis, severe left ventricular dysfunction, and persistent complete AVB, who was initially managed with extracorporeal membrane oxygenation and the Impella 5.5, along with temporary pacing. Due to the high risks of infection and bleeding, we implanted a leadless pacemaker (Micra AV system) as a temporary measure prior to CRT. Following Micra AV implantation, temporary pacing was successfully removed, and signs of infection and bleeding tendency improved. CRT was subsequently implanted, and Impella 5.5 was successfully weaned. Discussion: This case underscores the potential utility of a leadless pacemaker as a bridge to CRT therapy in patients with high risks of bleeding and infection. By employing this approach, the patient's clinical condition can be optimized, enabling the safe implantation of CRT. Further studies are warranted to validate our findings and evaluate the applicability of our novel strategy.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2025) conducted a case report in Fulminant myocarditis (n=1). Leadless pacemaker (Micra AV system) was evaluated. A leadless pacemaker (Micra AV system) was successfully used as a temporary bridge to cardiac resynchronisation therapy in a 64-year-old woman with fulminant myocarditis and high bleeding risk.
Synapse has enriched 10 related papers. Consider them for comparative context: